Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway (Q43691664)

25 November 2017

title

Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway (English)

1 reference

25 November 2017

N Mody

1

1 reference

25 November 2017

J Leitch

2

1 reference

25 November 2017

C Armstrong

3

1 reference

25 November 2017

J Dixon

4

1 reference

25 November 2017

P Cohen

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

502

1 reference

25 November 2017

issue

1-2

1 reference

25 November 2017

page(s)

21-24

1 reference

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

A synthetic inhibitor of the mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

Components of a new human protein kinase signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

Isolation of MEK5 and differential expression of alternatively spliced forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

[29] Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902651-5

10.1016/S0014-5793(01)02651-5

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference